Cathepsin's predictive role in breast cancer confirmed
This article was originally published in Clinica
Executive Summary
Immunoassay measurements of cathepsin-D can be used to predict the likelihood of relapse among breast cancer patients, researchers in the Netherlands have confirmed. Previous studies based on Western blotting or immunohistochemistry have produced conflicting results about the value of measuring tumour levels of the enzyme.